Phathom Pharmaceuticals, Inc.
VOQUEZNA
Eosinophilic Esophagitis (EoE)
Date
TBD
Phase 2 readout · Date TBD estimated
What's at stake
Phase 2 trial results for VOQUEZNA in Eosinophilic Esophagitis (EoE) are due Date TBD. A clean hit validates the program; a miss can gap the stock down hard.
Primary source
· SEC 8-K
verified 14h ago
“Topline results are anticipated in 2027.”